Correction to: EJNMMI Radiopharm Chem 6, 11 (2021)
https://doi.org/10.1186/s41181-021-00126-z
Following publication of the original article (Neves et al. 2021), some errors were identified in the article text:
-Page 3, Fig. 2, where it reads 1 it should read 5 and 18F should be at position 5 of the aromatic ring.
-Page 6, where it reads “MA > 96%”, it should read “Am > 37GBq/μmol”
-Page 7, where it reads “D- enantiomer of 2%” it should read “D- enantiomer of 4%”
-Page 8, where it reads “using a cPTC” it should read: “using different catalysts”.
-In page 8, Fig. 7, caption, where it reads “Chiral phase transfer catalysts (cPTC),”, it should read “Catalysts.”
-Pages 8–9, where it reads “6-[18F]fluoro-3,4-dimethoxybenzyl bromide” and “Sep-PakC18-Plus reactor.”, it should read “6-[18F]fluoro-3,4-dimethoxybenzaldehyde” and “Sep-PakC18-Plus”, respectively.
-Page 9, Fig. 8, where it reads “22 or 23”, it should read “23 or 24” and, number 24 under the structure, should be disregarded.
-Page 9, where it reads “Krasikova also prepared nitropiperonal 12 (Krasikova et al., 2004), using a combination of cPTC, 22.” it should read “Krasikova also prepared 6-[18F]FDOPA (Krasikova et al., 2004), using a combination of 22.”
-Page 10, caption of Table 2, where it reads “using cPTC as alkylation agent.” it should read “using different catalysts.”
-Page 10, Table 2, line 1, where it reads “PTC”, should read “catalyst”.
-Page 12, Table 3, entry 3, where it reads “31 ± 3”, it should read “31 ± 3*”, and where it reads “n.d. not described”, it should read “n.d. not described. *RCY for protected 6-[18F]FDOPA”.
-Page 13, where it reads, “6-[18F]FDOPA with 31 ± 3% RCY” it should read “the protected 6-[18F]FDOPA with 31 ± 3% RCY”.
-Page 14, where it reads “described in section 2.2.”, it should read “described previously”.
-Page 15, Fig. 14 where it reads “13, 14, 22 or 23”, it should read “14, 15, 23 or 24” and number 24 under the structure should be disregarded.
-Page 15, where it reads “MA 129500 Gbq/μmol”, it should read “Am 129,5 GBq/μmol”.
-Page 15, Fig. 15, where it reads “31, 32 and 33”, it should be read “37, 38 and 39”.
-Page 16, where it reads “nitroveratraldeyde 12”, it should read nitroveratraldeyde 11″ and, where it reads “precursor 31” it should read precursor 37″.
-There are multiple occurrences of [18F]. They should read [18F].
- MA is used throughout for Molar Activity. It should be Am.
-The following reference is missing: Mossine A V., Tanzey SS, Brooks AF, Makaravage KJ, Ichiishi N, Miller JM, et al. One-pot synthesis of high molar activity 6-[18F]fluoro-l-DOPA by Cu-mediated fluorination of a BPin precursor. Org Biomol Chem. 2019;17(38):8701–5.
The original article (Neves et al. 2021) has been corrected.
Reference
- Neves ÂCB, et al. Advances in the automated synthesis of 6-[18F]Fluoro-L-DOPA. EJNMMI Radiopharm Chem. 2021;6:11. doi: 10.1186/s41181-021-00126-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
